首页> 美国卫生研究院文献>Journal of Virology >Note: Human Immunodeficiency Virus Type 1 Envelope Epitope-Specific CD4+ T Lymphocytes in Simian/Human Immunodeficiency Virus-Infected and Vaccinated Rhesus Monkeys Detected Using a Peptide-Major Histocompatibility Complex Class II Tetramer
【2h】

Note: Human Immunodeficiency Virus Type 1 Envelope Epitope-Specific CD4+ T Lymphocytes in Simian/Human Immunodeficiency Virus-Infected and Vaccinated Rhesus Monkeys Detected Using a Peptide-Major Histocompatibility Complex Class II Tetramer

机译:注意:使用肽-主要组织相容性复合物II类四聚体检测到的猿猴/人免疫缺陷病毒感染和接种的恒河猴中的人类免疫缺陷病毒1型包膜抗原决定簇特异性CD4 + T淋巴细胞。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A tetrameric recombinant major histocompatibility complex (MHC) class II-peptide complex was used to quantitate human immunodeficiency virus type 1 (HIV-1) envelope (Env)-specific CD4+ T cells in vaccinated and in simian/human immunodeficiency virus (SHIV)-infected rhesus monkeys. A rhesus monkey MHC class II DR molecule, Mamu-DR*W201, and an HIV-1 Env peptide (p46) were employed to construct this tetrameric complex. A p46-specific proliferative response was seen in sorted, tetramer-binding, but not nonbinding, CD4+ T cells, directly demonstrating that this response was mediated by the epitope-specific lymphocytes. Although staining of whole blood from 10 SHIV-infected Mamu-DR*W201+ rhesus monkeys failed to demonstrate tetramer-binding CD4+ T cells (<0.02%), p46-stimulated peripheral blood mononuclear cells (PBMCs) from 9 of these 10 monkeys had detectable p46 tetramer-binding cells, comprising 0.5 to 15.2% of the CD4+ T cells. p46-stimulated PBMCs from 7 of 10 Mamu-DR*W201+ monkeys vaccinated with a recombinant canarypox virus–HIV-1 env construct also demonstrated p46 tetramer-binding cells, comprising 0.9 to 7.2% of the CD4+ T cells. Thus, Env p46-specific CD4+ T cells can be detected by tetrameric Mamu-DR*W201–p46 complex staining of PBMCs in both SHIV-infected and vaccinated rhesus monkeys. These epitope-specific cell populations appear to be present in peripheral blood at a very low frequency.
机译:用四聚体重组主要组织相容性复合体(MHC)II类肽复合物定量接种疫苗和猿猴中的人类免疫缺陷病毒1型(HIV-1)包膜(Env)特异性CD4 + T细胞/人免疫缺陷病毒(SHIV)感染的恒河猴。使用恒河猴MHC II类DR分子Mamu-DR * W201和HIV-1 Env肽(p46)来构建这种四聚体复合物。在分类的,四聚体结合但非结合的CD4 + T细胞中观察到了p46特异性增殖反应,直接表明该反应是由表位特异性淋巴细胞介导的。尽管对十只感染了SHIV的Mamu-DR * W201 + 恒河猴的全血染色未能显示四聚体结合CD4 + T细胞(<0.02%),但p46-在这10只猴子中,有9只受刺激的外周血单核细胞(PBMC)具有可检测到的p46四聚体结合细胞,占CD4 + T细胞的0.5%至15.2%。用重组金丝雀痘病毒–HIV-1 env疫苗接种的10只Mamu-DR * W201 + 猴子中有7只经p46刺激的PBMC也显示出p46四聚体结合细胞,占CD4的0.9%至7.2% + T细胞。因此,在SHIV感染和接种的恒河猴中,PBMC的四聚体Mamu-DR * W201-p46复合染色可以检测到Env p46特异性CD4 + T细胞。这些表位特异性细胞群似乎以非常低的频率存在于外周血中。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号